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Abstract
Electronic and biological applications of carbon nanotubes can be highly dependent on the species 
(chirality) of nanotube, purity, and concentration. Existing bulk methods, such as absorbance 
spectroscopy can quantify SP2 carbon based on spectral bands, but nanotube length distribution, 
defects, and carbonaceous impurities can complicate quantification of individual particles. We 
present a general method to relate the optical density of a photoluminescent nanotube sample to 
the number of individual nanotubes. By acquiring 3-dimensional images of nanotubes embedded 
in a gel matrix with a reducing environment, we quantified the individual nanotubes in a volume, 
resulting in a measurement of all emissive nanotubes. Via spectral imaging, we assessed structural 
impurities and precisely determined molar concentrations of the (8,6) and (9,4) nanotube species. 
We developed an approach to obtain the molarity of any structurally-enriched semiconducting 
single-walled carbon nanotube preparation on a per-nanotube basis.
Graphical Abstract
Semiconducting single-walled carbon nanotubes (SWCNTs) are a cylindrical form of 
nanocarbon that exhibit novel optical and electronic properties1. An as-produced nanotube 
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sample is intrinsically heterogeneous, containing nanotubes with different diameters, 
lengths, and chiral angles. Nanotube optical and electronic properties are highly dependent 
on diameter and roll up angle, which are defined by two integers (n,m) denoting nanotube 
species/chirality2. Absorption spectroscopy is the most commonly used analytical technique 
for characterizing a solution dispersion of a carbon nanotube sample2–4. Using 
experimentally calculated molar extinction coefficients, the concentration of nanotubes in 
solution can be obtained in terms of mass per volume5.
The characterization of SWCNT samples is confounded by their intrinsic heterogeneity. 
Although absorption cross sections are largely independent of average nanotube length6, 
recent ensemble7 and single-molecule studies8 have revealed the chirality-dependent 
absorption cross section of SWCNTs. Moreover, the distribution of chiralities in a bulk 
nanotube sample can vary based on the sample preparation technique. As a result, the 
concentration of carbon nanotubes calculated from ensemble measurements9 rely on 
extinction coefficients that may only be accurate for a specific sample preparation.
Current methods for mapping the chirality distribution of semiconducting carbon nanotubes 
include imaging approaches such as graphite-assisted atomic force microscopy (AFM), 
scanning tunneling microscopy (STM), transmission electron microscopy (TEM), electron 
diffraction, or spectroscopic techniques including Raman and photoluminescence 
spectroscopy10. Although photoluminescence excitation/emission (PLE) maps have emerged 
as the standard for analyzing semiconducting nanotubes in solution, artifacts such as 
bundling11 and exciton energy transfer12 can affect the PLE data.
The need for single-chirality semiconducting nanotubes for both electronic13 and 
biomedical1 applications has led to increasingly successful separation techniques. Variants 
of poly(9,9-di-n-octylfluorenyl-2,7-dyl) (PFO) have been used to selectively disperse and 
enrich specific SWCNT chiralities14. Surfactant-encapsulated SWCNTs have been sorted 
using density gradient ultracentrifugation15, gel-chromatography16, and polymer aqueous 
two-phase systems17,18 to provide highly-purified single nanotube chiralities in large-scale 
yields. Separation of biocompatible ssDNA-nanotube complexes has been accomplished 
using ion-exchange (IEX) high performance liquid chromatography (HPLC)19 and polymer 
aqueous two-phase systems20. The growth of single-chirality carbon nanotubes has also 
been demonstrated21.
Despite advances in nanotube purification procedures and new applications of chirality-
enriched nanotube samples, especially in biology and medicine15,22–24, current techniques 
for determining absorption coefficients for chirality-enriched SWCNT samples are lacking. 
Existing, indirect methods for calculating absorption coefficients require assumptions and 
introduce systematic uncertainties; reported absorption coefficients for the (6,5) nanotube 
vary over orders of magnitude7,25–27. Recently, absolute absorption cross sections of several 
SWCNT chiralities dispersed with sodium cholate or poly(9,9-di-n-octylfluorenyl-2,7-dyl) 
(PFO) were directly determined and normalized per carbon atom28. This was accomplished 
using 2D-short wave infrared (SWIR) fluorescence imaging to directly count individual 
SWCNTs within a precisely-constructed microfluidic chamber filled with sorbitol.
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Techniques to directly determine SWCNT absorption cross sections have been limited to 
bright surfactant and polymer-encapsulated SWCNTs. Thus, despite the high purity 
separation afforded by ssDNA-nanotubes, techniques to characterize the sample 
concentration are limited by the lower quantum yield of ssDNA nanotube preparations. 
Moreover, the aforementioned absorption coefficients, reported in units of cm2 per carbon 
atom and mass per volume, are not optimal for certain applications, such as biological 
sensing in live cells, wherein each fluorescent nanotube represents a distinct sensing 
element24. Knowledge of the nanotube concentration in terms of sensing elements per unit 
volume will allow improved control over the sensor/analyte ratio. Additionally, in the 
fabrication of electronics, the transfer characteristics, threshold voltage, and even field effect 
mobility can depend on the nanotube deposition density on the device29. Thus, a technique 
for obtaining nanotube concentration and chirality information at the single-nanotube level 
would be valuable for multiple fields.
Here, we report a single nanotube counting method to relate the molar concentration of 
chirality-enriched semi-conducting SWCNTs to the optical density (OD) measured in 
solution. Using a near-infrared microscopy system coupled to a piezo z-axis stage, we 
explicitly counted emissive nanotubes within an optically-defined volume. The bright 
emission intensity of IEX-purified (8,6) and (9,4) nanotube chiralities embedded in an 
agarose gel, acquired following on-resonance excitation with a 730 nm laser, was further 
enhanced using a reducing agent30. We used hyperspectral microscopy to assess the 
monodispersity of nanotube chiralities on the single-nanotube level and correct for 
impurities31. The number of imaged nanotubes scaled linearly with the absorbance peak of 
the first electronic transition (E11) thereby directly relating the experimentally determined 
molar concentrations of chirality-separated (8,6) and (9,4) nanotube samples with their 
absorption bands. The generalizability and accuracy of this method in determining molarity 
could enable investigators to obtain chirality-specific concentrations of any semiconducting 
carbon nanotube preparation.
EXPERIMENTAL SECTION
Detailed information on the chemical reagents used, preparation of the ssDNA-nanotube 
dispersions, IEX purification, instrumentation, data acquisition, and analysis are provided in 
the Supporting Information.
Preparation of chirality-enriched DNA-SWCNT samples
Single-walled carbon nanotubes produced by the HiPco process (Unidym) were suspended 
via sonication with single-stranded DNA for 30 minutes, followed by 30 minutes of 
ultracentrifugation. The (CCG)4 and (GT)6 ssD-NA oligonucleotides were used to 
selectively enrich the (9,4) and (8,6) species, respectively, using IEX-HPLC19. The purity of 
each sample was assessed both via absorption spectroscopy (Figure 1) and two-dimensional 
photoluminescence excitation/emission spectroscopy (Figure S1), while length distributions 
were assessed with atomic force microscopy (Figure S2).
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Hyperspectral microscopy
Hyperspectral microscopy, a recently developed technique that allows every pixel of a near-
infrared fluorescent image to be spectrally resolved31, was used both to correct for 
impurities in chirality-enriched SWCNT samples, as well as to confirm that single regions of 
interest (ROI’s) within agarose gels did not represent nanotube bundles or aggregates.
Immobilization and direct counting of ssDNA-SWCNTs
To directly count the number of fluorescent DNA-SWCNTs within known volumes, the 
nanotubes were immobilized at four different dilution factors in 1% low melt agarose gels. 
The intensity of nanotube emission within the gels was increased via supplementation with 
reducing agents which are known to enhance the photoluminescence quantum yield of 
carbon nanotubes (Figure 2, S3)30.
Nanotubes were excited at 730 nm, nearly on-resonance with both the (8,6) and (9,4) 
species, and imaged using a 2D near-infrared InGaAs detector. We used a 100X (1.40 NA) 
oil objective to excite a ~ 90 μm diameter area with a 2W CW laser. Due to power loss 
through beam shaping optics, this resulted in a power density of ~ 10.0 kW/cm2 at the 
sample. Using an automated stage with z-axis control, 3 dimensional image stacks were 
acquired with a 200 nm step size to optically define the imaging volume. This allowed for 
nanotubes to be imaged and directly counted for each dilution of the chirality-enriched 
samples within volumes of 154 pL, using ImageJ. For each nanotube chirality, the number of 
emissive nanotubes was counted in 3 sections per agarose gel and for 3 gels per dilution 
factor for a total of nine technical replicates per sample/dilution factor.
RESULTS AND DISCUSSION
Prior to performing nanotube counting experiments, we tested the effect of reducing agents 
on nanotube emission from within 1% agarose gels. In solution, the presence of reducing 
agents is known to increase the fluorescence intensity of DNA-SWCNTs30. This occurs due 
to the passiviation of defective SWCNTs via the donation of electrons to SWCNT 
sidewalls30. A similar effect was seen in agarose gels, as supplementing gels with reducing 
agents such as ascorbic acid or Trolox resulted in an increase in the intensity of DNA-
SWCNTs embedded in gels and was stable for over 3 hours (Figure 2, S3–4). Thus, for all 
counting experiments, 1% agarose gels were supplemented with 2 mM Trolox (Figure 3).
Hyperspectral microscopy of Trolox-supplemented agarose gels containing unsorted 
ss(GT)6-SWCNTs showed a single emission peak for over 97% of the ROI’s, confirming 
that single nanotubes could be observed and that the DNA-nanotube complexes represented 
individual nanotubes instead of bundles or aggregates (Figure S5).
We counted individual nanotubes within the gels at four dilution factors of the stock sample 
concentration. To ensure that we were not systematically undercounting shorter and dimmer 
nanotubes, we adapted a technique from Streit et al32. Trolox-supplemented agarose gels 
containing the (GT)6-(8,6) sample were imaged under different excitation powers. As the 
excitation power was increased from 1.12 kW/cm2 to 9.12 kW/cm2, the average number of 
nanotubes detected per field of view increased from 1.7 to 22.3 (Figure S6). However, when 
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the excitation power was increased further to 12.9 kW/cm2, no statistically significant 
increase in the number of detected nanotubes was observed, and a logistic fit of the data 
suggested that no further increase would be seen with increasing laser power (Figure S6). 
Since all counting experiments were performed at 12.9 kW/cm2, this suggests that we did 
not systematically undercount dim nanotubes. Inspection of SWCNT absorption spectra 
shows distinct nanotube peaks with relatively low background (Figure S7), indicating that 
the sample did not contain a large fraction of defective and thus dark SWCNTs33,34. When 
counting both the ss(CCG)4-(9,4) and ss(GT)6-(8,6) enriched samples, the number of 
nanotubes detected in the gels scaled linearly with dilution factor, with r2 values of 0.97. 
This number increased to 0.99 for both samples after applying the mild assumption that a 
dilution factor of 0 yields a SWCNT count of 0 (Figure S8). The strong linear relation 
between the sample dilution and the number of individual nanotubes counted indicates the 
robustness and accuracy of the counting methodology.
To effectively determine the molarity of the (8,6) and (9,4) chiralities specifically, a 
correction factor was established to account for the other chiralities that may have been 
observed in the agarose gels. For the (8,6)-enriched sample, examination of its PL plot 
(Figure S1) indicates the presence of an impurity in the form of the (9,5) nanotube. Using 
hyperspectral microscopy, emission spectra were acquired for 384 nanotubes adsorbed to a 
glass surface under 730 nm excitation. Upon fitting the emission spectra of each nanotube to 
assign chirality, 381 nanotubes were identified as the (8,6) species (Figure S9), indicating 
that although (9,5) nanotubes were present in the sample, they were not easily visualized 
with off resonance excitation, and they did not significantly contribute to the nanotube 
counts. Thus, for the (8,6) chirality, only a small correction factor of 0.992 was required.
Examination of the PL plot of the (9,4) sample (Figure S1) showed a significant amount of 
impurities in the form of the (7,6) nanotube which emits in a similar range as the (9,4) 
chirality but has a different excitation maximum. Thus, we developed an alternate approach 
to correct for the impurities.
We first used hyperspectral microscopy to assess chiralities emitting at different wavelengths 
than the (9,4) species. Using hyperspectral microscopy, we found that 4% (10/236) of 
nanotubes observed in the sample emitted at wavelengths denoting chiralities other than 
(7,6) or (9,4). Due to their overlapping emission bands, the (7,6) and (9,4) nanotubes could 
not be spectrally resolved.
We then developed a method to assess other chiralities with the same emission wavelength 
but different excitation wavelengths. In brief, nanotubes from the (9,4) enriched sample were 
immobilized on a glass surface. Due to the differing excitation maxima of the (9,4) and (7,6) 
nanotubes, these chiralities were resolved by exciting the sample and acquiring images 
sequentially with 730 nm and 660 nm lasers set to the same power. Nanotubes emitting 
under 730 nm excitation were then analyzed under 660 nm excitation to determine the effect 
on emission intensity (Figure 4). A total of 240 nanotubes were analyzed, out of which 33 
became brighter under 660 nm excitation. We thus obtained a correction factor of 0.86; i.e., 
14% of the nanotubes detected under 730 nm excitation were actually the (7,6) species.
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To determine a final correction factor for the (9,4) sample, the correction factor that was 
determined via hyper-spectral microscopy (0.96), was multiplied by the correction factor 
that was determined via the differing excitation maxima of the (9,4) and (7,6) nanotubes 
(0.86). This gave a final correction factor of 0.82. Corrected molarities of single nanotubes 
scaled linearly with the dilution factor of the sample from the initial stock (Figure 5). The r2 
values were greater than 0.99 for both samples after carrying over the assumption that a 
dilution factor of 0 corresponds to a nanotube count of 0. The line was then used to 
extrapolate the molarity of the nanotube samples at higher concentrations suitable for 
ensemble absorbance measurements. Baseline subtraction was performed on the absorbance 
spectra of each sample at these dilutions, such that the E11 absorption peaks could be related 
to the molarity of each chirality-resolved nanotube species (Figure S10–11). For the 
ss(CCG)4-(9,4) sample, this required deconvolution of the (9,4) and (7,6) absorption peaks 
(Figure S12).
From these calculations, we plotted the extrapolated nanotube molarities against OD of the 
corresponding sample dilution, once again applying the previously described assumption 
regarding an optical density of 0 AU. Linear fits of calculated molarity vs. OD for the (9,4) 
and (8,6) samples gave r2 values of 0.99 and 0.98, respectively (Figure 5). This linear 
relationship is derived purely from experimental data for this particular sample and does not 
rely on references, calculations, or tabulated values from different sample preparations. 
Taking into account the 1 cm path length used for absorbance measurements, we can 
calculate molar absorptivity/extinction coefficients on a per nanotube basis for our samples. 
These calculations gave values of 0.205 nMSWCNT−1 · cm−1 and 0.510 nMSWCNT−1 · cm−1 
for the (9,4) and (8,6) samples respectively.
The above values differ from previously reported extinction coeficcients and absorption 
cross sections in that they are normalized by nanotube concentration rather than the number 
of carbon atoms in the sample, making them more relevant to biosensing and imaging 
related applications. It is important to note however, that unlike previously reported 
absorption cross sections for the E11 absorption peak (σ11)28,35,36, the values reported here 
are dependent on the SWCNT length distribution, as two SWNT preparations with varying 
length distributions may contain equal concentrations of carbon atoms despite containng 
different numbers of nanotubes per unit volume. This highlights the importance of applying 
the developed method to individual SWCNT preparations. To convert the values obtained 
using the described method to the carbon atom based σ11 values reported elsewhere, one 
only needs to take into account the average nanotube length and the number of carbon atoms 
present per nm for the SWCNT chirality of interest. Converting the per nanotube extinction 
coefficients to absorption cross sections in units of cm2/carbon atom (Catom) gives values of 
5.15 × 10−17 cm2/Catom and 18.56 × 10−17 cm2/Catom, for the (9,4) and (8,6) samples 
respectivey, which fall well within the range of previously published values28,35,36.
Conclusion
In this work, we described the development of a set of imaging methods to relate DNA-
nanotube OD at the E11 to concentration, in terms of the emissive nanotube number per unit 
volume or molarity, for any structurally-enriched semiconducting SWCNT preparation. We 
Galassi et al. Page 6
Anal Chem. Author manuscript; available in PMC 2017 July 17.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
applied this method to map OD to molarity for the (8,6) and (9,4) nano-tubes and calculate 
their extinction coefficients based on the number of individual nanotubes rather than total 
graphitic carbon. This method is applicable to any chirality-enriched nanotube sample. The 
technique allows one to account for relatively dim nanotube preparations and use 
commercially available instrumentation. The straightforward data acquisition and analysis 
could facilitate the use of this method for routine sample characterization. Such methods are 
useful for many SWCNT-based applications, particularly electronic and biomedical 
applications where semiconducting nanotubes function as important components, and where 
interactions with living systems are important.
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Figure 1. 
Baseline-subtracted absorption spectra of chirality-enriched ssDNA-nanotube samples. A) 
Absorption spectrum of the (9,4)-enriched ss(CCG)4-SWCNT sample. Inset: Deconvolution 
of the (9,4) electronic transition peak from the (7,6) electronic transition peak. B) 
Absorption spectrum of the (8,6)-enriched ss(GT)6-SWCNT sample.
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Figure 2. 
Near infrared images of DNA-SWCNTs within agarose gels supplemented with ascorbic 
acid or Trolox.
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Figure 3. 
Imaging single emissive SWCNTs immobilized in an agarose gel. A) Schematic of nanotube 
immobilization procedure. B) A deconvolved 3D image of the agarose gel showing emission 
of single nanotubes.
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Figure 4. 
Dual-excitation near-infrared fluorescence microscopy of single nanotubes to determine 
chiral purity. A) A representative field of view under 730 nm or 660 nm excitation, with 
selected ROIs shown. Scale bar = 10 μm. B) The intensity line profile of an individual 
nanotube under 730 nm and 660 nm excitation. C) Graph comparing the peak emission 
height of each selected ROI under 730 nm and 660 nm excitation.
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Figure 5. 
Linear relation between nanotube concentration, deduced via microscopy, and the dilution 
factor or optical density of each sample. A) Corrected molarity vs. dilution factor for the 
(9,4) sample. B) Corrected molarity vs. dilution factor for the (8,6) sample. C) Calculated 
molarity vs. OD of the E11 absorption peak for the (9,4) nanotube. D) Calculated molarity 
vs. OD of the E11 absorption peak for the (8,6) nanotube.
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